PAR 2.00% 24.5¢ paradigm biopharmaceuticals limited..

Ann: Change of Director's Interest Notice, page-12

  1. 696 Posts.
    lightbulb Created with Sketch. 46
    I agree that this is allocation of shares is unwarranted given the delays and the situation of the company, however I would like to know others opinions as to why they think Donna Skerret does not deserve this.
    My opinion is that she does not deserve it because the actions taken by her were not significant enough to be worth 780,000. Also that the company is not in a good enough financial position to be awarding shares in this way. If we were making $$$ or hadn't slipped the timelines and a call raise was totally off the table it would be a different story
    Contribute if you care to.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.005(2.00%)
Mkt cap ! $85.70M
Open High Low Value Volume
25.0¢ 25.5¢ 24.0¢ $141.8K 569.9K

Buyers (Bids)

No. Vol. Price($)
5 45098 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 17277 2
View Market Depth
Last trade - 15.39pm 11/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.